 |
(-)-17-(cyclopropylmethyl)-3,14 ß-dihydroxy-4,5 a-epoxy-6ß-[N-methyl-trans-3-(3-furyl) acrylamido] morphinan hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Uremic pruritus |
| EU Market Approval | EU |
| EU Designation Date | 2002-09-11 00:00:00 |
| Sponsor | Toray International Europe GmbH |
